No Data
No Data
Demystifying Macrogenics: Insights From 14 Analyst Reviews
Analysts' ratings for Macrogenics (NASDAQ:MGNX) over the last quarter vary from bullish to bearish, as provided by 14 analysts.In the table below, you'll find a summary of their recent ratings, reveal
Macrogenics Is Maintained at Buy by BTIG
Macrogenics Is Maintained at Buy by BTIG
Macrogenics Price Target Cut to $9.00/Share From $24.00 by BTIG
Macrogenics Price Target Cut to $9.00/Share From $24.00 by BTIG
Express News | BTIG Maintains Buy on Macrogenics, Lowers Price Target to $9
B.Riley Financial Maintains Macrogenics(MGNX.US) With Buy Rating, Cuts Target Price to $18
B.Riley Financial analyst Mayank Mamtani maintains $Macrogenics(MGNX.US)$ with a buy rating, and adjusts the target price from $25 to $18.According to TipRanks data, the analyst has a success rate of
Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Iovance Biotherapeutics (IOVA)
No Data
Amp : Source?